Undiagnosed Diseases Overwhelm NIH

An NIH program to identify mystery diseases has stopped accepting applications after being flooded with cases.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Clinical Research CenterNATIONAL INSTITUTE OF HEALTH

A National Institutes of Health program to diagnose rare diseases is, for now, no longer accepting new applications. After receiving more than 5400 queries and 1900 applications since its inception in 2008, the Undiagnosed Diseases Program, which aims to gain basic knowledge of rare human diseases and to aid those suffering from them, decided to take a break from new applications to eliminate the backlog of cases it has already taken on.

Reviewers selected 450 applicants, whose medical records provided promising leads, and NIH investigators have looked into 350 of those cases so far. Selected patients come to the NIH’s Bethesda, Maryland, clinic for a complete medical workup by NIH staff, including genome sequencing. Earlier this year, the program published its first findings, identifying in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies